Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-d-glucose with positron emission tomography in patients with small cell lung cancer

Arslan N., Tuncel M., Kuzhan O., Alagoz E., Budakoglu B., Ozet A., ...More

ANNALS OF NUCLEAR MEDICINE, vol.25, no.6, pp.406-413, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 25 Issue: 6
  • Publication Date: 2011
  • Doi Number: 10.1007/s12149-011-0478-y
  • Journal Name: ANNALS OF NUCLEAR MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.406-413
  • Keywords: FDG-PET, Small cell lung cancer, Staging, Quantitative PET
  • Hacettepe University Affiliated: Yes

Abstract

The objective of this study is to determine whether 2-deoxy-2-[18F] fluoro-d-glucose with positron emission tomography (FDG-PET) imaging and quantitative PET parameters can predict outcome and differentiate patients with limited disease (LD) from extensive disease (ED) in patients with small cell lung cancer (SCLC).